// App-Quantinova.ai

589 : The value of tamoxifen and trastuzumab in breast cancer treatment: A study based on uptake and use in Sweden.

Researchers

Presenter

  • Nils Erik Wilking

Principal Investigators

  • Adam Lundqvist

  • Bengt Jnsson

  • Ulf Gerdtham

  • Ulf Persson

  • Katarina Steen-Carlsson

Medical Centers

  • Stockholm School of Economics, Stockholm, Sweden

  • Karolinska Institutet, Stockholm, SwedenIHE, Lund, Sweden

Locations

  • Sweden

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Tuberculosis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Trastuzumab

  • Tamoxifen

Outcome

  • Positive

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved